Clinical trial
Doppler or Amniocentesis to Predict Fetal Anemia
NCT00295516 · University of Toronto, Other · Completed
Key facts
| NCT number | NCT00295516 |
|---|---|
| Title | Doppler or Amniocentesis to Predict Fetal Anemia |
| Official title | Minimally Invasive Management of Rh Alloimmunization: Can Amniotic Fluid DeltaOD450 Measurements Be Replaced by Doppler Studies? |
| Lead sponsor | University of Toronto, Other |
| Collaborators | The Physicians' Services Incorporated Foundation Stichting Oranjekliniek, The Netherlands |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rh Isoimmunization |
| Intervention type | Procedure |
| Interventions | Fetal Middle Cerebral Artery Doppler measurement |
| Enrollment | 157 |
| Start date | Oct 1, 2000 |
| Completion | Aug 1, 2004 |
| First posted | Feb 23, 2006 |
| Last update posted | May 24, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: